πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7557196

hGC-1, a gene encoding a member of the olfactomedin-related protein family

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553936

Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7553490

Vaccines against Escherichia coli O157 infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550275

Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypep

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547762

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547773

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547712

Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544789

DNA encoding Toxoplasma gondii rDGP5p protein

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544713

Compounds and methods for delivery of prostacyclin analogs

United Therapeutics Corporation Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541035

Immunogenic peptides for the treatment of prostate and breast cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541040

Chimeric molecule for the treatment of th2-like cytokine mediated disorders

The United States of America as represented by the Department of Health and Human Serivces Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534565

DLC-1 gene deleted in cancers

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531635

MATER-protein specific antibodies and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531352

Inducible plasmid vector encoding TGF-Ξ² and use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527802

Vaccine for transcutaneous immunization

The United States of America as represented by the Secretary of the Army Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528274

Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527797

Vibrio cholerae 0139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524508

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524516

Corrosion inhibiting mildew remover kit

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted